CClinicalTrials.gg
Not yet recruitingNCT07867119Updated Oct 9, 2026

Therapeutic Benefits of Pareidolia in Acute Traumatic Brain Injury Patients

An interventional study of Therapeutic Benefits of Pareidolia and Active Comparator #1 in Traumatic Brain Injuries, sponsored by Shirley Ryan AbilityLab. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study will investigate whether viewing and identifying meaningful shapes or images hidden within nature pictures (pareidolia) can improve motivation and engagement in rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Participants will be randomly assigned to either a pareidolia-based activity group or a control group and will complete therapy sessions and assessments over approximately three weeks. The findings may help identify a simple, low-risk approach to enhancing rehabilitation participation after TBI

Read the detailed description

This study examines whether pareidolia, the experience of seeing meaningful images or patterns in ambiguous visual stimuli (such as faces in clouds), can improve motivation and engagement during rehabilitation therapy for adults with mild to moderate traumatic brain injury (TBI). Approximately 50 participants receiving inpatient rehabilitation at Shirley Ryan AbilityLab will be randomly assigned to either a pareidolia intervention group, which will participate in a guided scavenger hunt using nature images containing hidden pareidolic patterns, or a control group that will view similar nature images without searching for hidden shapes. Over a 3-week period, participants will complete 4 to 6 intervention sessions along with pre- and post-study assessments measuring motivation, therapy engagement, mood, anxiety, apathy, and, in some cases, eye-movement patterns. The study involves minimal risk, primarily mild fatigue or frustration during activities, and while participants may not directly benefit, the findings may help identify a simple, low-risk approach to enhancing participation and engagement in rehabilitation therapy for individuals recovering from TBI.

02

Conditions studied

  • Traumatic Brain Injuries

Keywords

  • TBI, Depression, Mood, Engagement, Anxiety, Pareidolia
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's planned enrollment of 50 is below the median of 56 across 1,133 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Shirley Ryan AbilityLab is the lead sponsor of 179 studies on the registry; 45 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Diagnosis of mild-to-moderate traumatic brain injury (TBI) based on hospital chart review.

Age 18 to 80 years. Premorbidly fluent in English. Education level greater than 8th grade. Corrected visual acuity of at least 20/40.

-

Exclusion criteria

Exclusion Criteria:

Other neurological disorders affecting cognition or language, active substance use, epilepsy, history of psychosis or schizophrenia, hemianopia, severe spatial neglect, isolation precautions, severe visual impairment.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Structured pareidolia-based therapeutic activity.

    Participants complete a structured pareidolia scavenger hunt involving identification of hidden images and shapes within nature-based pictures during rehabilitation sessions.

    Behavioral: Therapeutic Benefits of Pareidolia

  • Active comparator
    Nature-image viewing activity without pareidolia exposure.

    Participants complete a comparable walking and nature-image viewing activity without pareidolic images or instructions to search for hidden shapes.

    Behavioral: Active Comparator #1

Interventions

  • BehavioralTherapeutic Benefits of Pareidolia

    A clinician-guided pareidolia intervention in which participants identify and describe meaningful shapes or images embedded within nature-based visual stimuli during structured rehabilitation sessions. The activity is delivered as a progressive scavenger hunt with varying levels of image difficulty.

  • BehavioralActive Comparator #1

    Participants complete a comparable walking and nature-image viewing activity without pareidolic images or instructions to identify hidden shapes or patterns.

06

What researchers measure

Primary outcomes

  1. Change in Therapy Engagement

    Therapy Engagement and Motivation as measured by the Rehabilitation Therapy Engagement Scale (RTES)

    Time frame: 4 weeks

07

Study locations

1 site
  • Shirley Ryan Ability Lab
    Chicago, Illinois 60610, United States
08

References and documents

Individual participant data

Plan to share: Undecided — We have not decided in what format to share the data and whether to share summary or individual data.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07867119
Lead sponsor
Shirley Ryan AbilityLab
Responsible party
Sponsor
First posted
Oct 9, 2026
Start date
Oct 10, 2026 (estimated)
Primary completion
Aug 24, 2029 (estimated)
Completion
Aug 24, 2029 (estimated)
Last update
Oct 9, 2026

Study contacts

Sameer A Ashaie, PhD
Contact
sashaie@sralab.org
3122386154
Brook Boxrud
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion